Stephen E. Jones, MD

home / authors / stephen-e-jones-md

Articles

Cost-Effectiveness of Docetaxel-Cyclophosphamide Versus Doxorubicin-Cyclophosphamide for Breast Cancer

Melissa F. Thompson, BSc, MBA;Lei Chen, MD, PhD;Muralikrishna Tangirala, MS, MPH;Lina Asmar, PhD;Stephen E. Jones, MD

October 1st 2011

Compared with doxorubicin plus cyclophosphamide, docetaxel plus cyclophosphamide was highly cost-effective for adjuvant treatment of operable breast cancer.

Published: October 23rd 2024 | Updated: October 24th 2024

What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders

Published: January 18th 2016 | Updated: October 18th 2024

10 Pharmacy Quotes That Will Make You Rethink the Profession

Published: September 22nd 2015 | Updated: October 14th 2024

Gabapentin Differs From Pregabalin in Several Key Ways

From Dogs to Human: AI-Powered Drug Response Prediction Technology Shows Improved Clinical Outcomes in Oncology

Published: December 2nd 2024 | Updated: December 28th 2024

From Dogs to Humans: AI-Powered Drug Response Prediction Technology Demonstrates Improved Clinical Outcomes in Oncology

Published: December 20th 2024 | Updated: December 28th 2024

Examining the 505(b)(2) Pathway and Implementation into EHR

Published: January 25th 2024 | Updated: December 28th 2024

Understand the Fundamentals of Treating Older Patients with Atopic Dermatitis

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Stephen E. Jones, MD

Articles

Latest Updated Articles